Currently, out of the existing stock ratings of Amit Hazan - 17 which are a Sell (12.32%), 55 which are a Hold (39.86%), 66 which are a Buy (47.83%)

Amit Hazan

Work Performance Price Targets & Ratings Chart

Analyst Amit Hazan works at GOLDMAN SACHS and is covering the Healthcare sector with 254 price targets and ratings displayed on 23 stocks. Previously, Amit Hazan worked at CITI.

Amit Hazan's average stock forecast success ratio is 71.18% with an average time for price targets to be met of 185.3 days.

Most recent stock forecast was given on BVS, Bioventus at 30-Nov-2022.

Wall Street Analyst Amit Hazan

Analyst best performing recommendations are on ATEC (ALPHATEC HOLDINGS).
The best stock recommendation documented was for ATEC (ALPHATEC HOLDINGS) at 8/8/2022. The price target of $9.5 was fulfilled within 4 days with a profit of $1.51 (18.9%) receiving and performance score of 47.25.

Average potential price target upside

of $36.01 (17.61%) on BDX (BECTON, DICKINSON AND COMPANY).
of $27.12 (34.48%) on MDT (MEDTRONIC PLC).
of $26.94 (23.16%) on JNJ (JOHNSON & JOHNSON).

ABT Abbott Laboratories BAX Baxter International BDX Becton, Dickinson and Company BSX Boston Scientific BVS Bioventus EW Edwards Lifesciences INSP Inspire Medical Systems ISRG Intuitive Surgical JNJ Johnson & Johnson MDT Medtronic plc SYK Stryker VAR ZBH Zimmer Biomet Holdings ESTA Establishment Labs Holdings AFIB Acutus Medical ATEC Alphatec Holdings LIVN LivaNova PLC SHC Sotera Health Company BLCO OM SKIN AGTI Agiliti PRCT

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

David Lewis (MORGAN STANLEY)